Delivery Order SPE2DB22D2206-SPE2DB24FFZ21
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGEML product. The contract, valued at $1,408.95, has an ultimate completion date of March 25, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, to...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,070.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,374,156 units of the TWINRIX VACCINE SYRINGEML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- The Defense Logistics Agency (DLA) awarded a $1,008.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TWINRIX VACCINE SYRINGEML. The $11,112.95 contract has a performance period through January 29, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp has received numerous prior awards from DLA Troop Support Medical to supply pharmaceuticals, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML pharmaceutical product. The $1,352.76 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and has received numerous prior contracts from DLA to supply pharmaceuticals and medical supplies in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,352.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TWINRIX VACCINE SYRINGEML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $231,266.24 firm fixed price delivery order contract to provide TWINRIX VACCINE SYRINGEML. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of TWINRIX vaccine syringes. The contract, valued at $1,846.48, has a completion date of July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor and for-profit organization, to provide the TWINRIX VACCINE SYRINGE ML product. The $9,131.33 delivery order has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation and serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $6,403.66 firm fixed-price delivery order contract for TWINRIX VACCINE SYRINGEML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFZ21Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE medication. The $13,660.52 contract has a performance period through March 8, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp has received numerous similar pharmaceutical and medical supply contracts from DLA to support military treatment programs and facilities. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical on behalf of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 3/7/24 |